CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.35 GBX | 0.00% |
|
+4.82% | +81.25% |
| May. 24 | Cambridge Nutritional Sciences appoints James Copper as COO | AN |
| May. 24 | Cambridge Nutritional Sciences Names COO | MT |
| Sales 2024 * | 9M 11.45M | Sales 2025 * | - | Capitalization | 10.35M 13.17M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.27M | Net income 2025 * | - | EV / Sales 2024 * | 0.68 x |
| Net cash position 2024 * | 4.2M 5.34M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-8.7
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 week | +4.82% | ||
| Current month | +4.82% | ||
| 1 month | +10.13% | ||
| 3 months | +64.15% | ||
| 6 months | +64.15% | ||
| Current year | +81.25% |
1 week
4.17
4.45
1 month
3.814.45
Current year
2.304.45
1 year
1.664.45
3 years
1.6678.00
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 4.35 | 0.00% | 335,151 |
| 24-06-06 | 4.35 | 0.00% | 129,784 |
| 24-06-05 | 4.35 | +2.35% | 1,110,114 |
| 24-06-04 | 4.25 | 0.00% | 136,116 |
| 24-06-03 | 4.25 | +2.41% | 317,248 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +81.25% | 13.17M | |
| -6.76% | 11.98B | |
| -5.68% | 8B | |
| +8.91% | 5.85B | |
| +28.87% | 5.54B | |
| -15.84% | 3.84B | |
| +10.70% | 2.66B | |
| -60.92% | 2.62B | |
| -6.99% | 2.33B | |
| +15.67% | 2B |
- Stock Market
- Equities
- ODX Stock
